nodes	percent_of_prediction	percent_of_DWPC	metapath
Levosimendan—PDE3A—Aminophylline—chronic obstructive pulmonary disease	0.764	1	CbGbCtD
Levosimendan—TNNC1—Striated Muscle Contraction—TNNT2—chronic obstructive pulmonary disease	0.00927	0.185	CbGpPWpGaD
Levosimendan—TNNC1—Striated Muscle Contraction—TNNT2—chronic obstructive pulmonary disease	0.00788	0.157	CbGpPWpGaD
Levosimendan—TNNC1—Muscle contraction—TNNT2—chronic obstructive pulmonary disease	0.00623	0.124	CbGpPWpGaD
Levosimendan—TNNC1—connective tissue—chronic obstructive pulmonary disease	0.00468	0.171	CbGeAlD
Levosimendan—Extrasystoles—Aminophylline—chronic obstructive pulmonary disease	0.00464	0.0292	CcSEcCtD
Levosimendan—Atrial fibrillation—Roflumilast—chronic obstructive pulmonary disease	0.00448	0.0282	CcSEcCtD
Levosimendan—Ventricular extrasystoles—Aminophylline—chronic obstructive pulmonary disease	0.00432	0.0272	CcSEcCtD
Levosimendan—KCNJ8—respiratory system—chronic obstructive pulmonary disease	0.00399	0.146	CbGeAlD
Levosimendan—Ventricular tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00368	0.0232	CcSEcCtD
Levosimendan—Extrasystoles—Formoterol—chronic obstructive pulmonary disease	0.00353	0.0222	CcSEcCtD
Levosimendan—Extrasystoles—Arformoterol—chronic obstructive pulmonary disease	0.00353	0.0222	CcSEcCtD
Levosimendan—Myocardial ischaemia—Salbutamol—chronic obstructive pulmonary disease	0.00349	0.0219	CcSEcCtD
Levosimendan—Extrasystoles—Salbutamol—chronic obstructive pulmonary disease	0.00333	0.021	CcSEcCtD
Levosimendan—Ventricular extrasystoles—Formoterol—chronic obstructive pulmonary disease	0.00329	0.0207	CcSEcCtD
Levosimendan—Ventricular extrasystoles—Arformoterol—chronic obstructive pulmonary disease	0.00329	0.0207	CcSEcCtD
Levosimendan—KCNJ8—bronchus—chronic obstructive pulmonary disease	0.00328	0.12	CbGeAlD
Levosimendan—KCNJ8—smooth muscle tissue—chronic obstructive pulmonary disease	0.00321	0.118	CbGeAlD
Levosimendan—Atrial fibrillation—Aminophylline—chronic obstructive pulmonary disease	0.00299	0.0188	CcSEcCtD
Levosimendan—KCNJ8—trachea—chronic obstructive pulmonary disease	0.00295	0.108	CbGeAlD
Levosimendan—TNNC1—lung—chronic obstructive pulmonary disease	0.00282	0.103	CbGeAlD
Levosimendan—Cardiac disorder—Roflumilast—chronic obstructive pulmonary disease	0.00273	0.0172	CcSEcCtD
Levosimendan—Hypokalaemia—Aminophylline—chronic obstructive pulmonary disease	0.00258	0.0162	CcSEcCtD
Levosimendan—Mental disorder—Roflumilast—chronic obstructive pulmonary disease	0.00257	0.0162	CcSEcCtD
Levosimendan—PDE3A—smooth muscle tissue—chronic obstructive pulmonary disease	0.00256	0.0939	CbGeAlD
Levosimendan—Malnutrition—Roflumilast—chronic obstructive pulmonary disease	0.00256	0.0161	CcSEcCtD
Levosimendan—Atrial fibrillation—Formoterol—chronic obstructive pulmonary disease	0.00228	0.0143	CcSEcCtD
Levosimendan—Atrial fibrillation—Arformoterol—chronic obstructive pulmonary disease	0.00228	0.0143	CcSEcCtD
Levosimendan—KCNJ11—Type II diabetes mellitus—ADIPOQ—chronic obstructive pulmonary disease	0.00223	0.0444	CbGpPWpGaD
Levosimendan—Atrial fibrillation—Salbutamol—chronic obstructive pulmonary disease	0.00215	0.0135	CcSEcCtD
Levosimendan—KCNJ8—lung—chronic obstructive pulmonary disease	0.00212	0.0776	CbGeAlD
Levosimendan—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00205	0.0129	CcSEcCtD
Levosimendan—Hypokalaemia—Formoterol—chronic obstructive pulmonary disease	0.00196	0.0123	CcSEcCtD
Levosimendan—Hypokalaemia—Arformoterol—chronic obstructive pulmonary disease	0.00196	0.0123	CcSEcCtD
Levosimendan—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.00189	0.0119	CcSEcCtD
Levosimendan—Hypokalaemia—Salbutamol—chronic obstructive pulmonary disease	0.00185	0.0117	CcSEcCtD
Levosimendan—KCNJ11—Regulation of insulin secretion—RAPGEF3—chronic obstructive pulmonary disease	0.00182	0.0364	CbGpPWpGaD
Levosimendan—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.0018	0.0113	CcSEcCtD
Levosimendan—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00179	0.0112	CcSEcCtD
Levosimendan—PDE3A—lung—chronic obstructive pulmonary disease	0.00169	0.0619	CbGeAlD
Levosimendan—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.00168	0.0105	CcSEcCtD
Levosimendan—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.00162	0.0102	CcSEcCtD
Levosimendan—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.00161	0.0101	CcSEcCtD
Levosimendan—KCNJ11—Integration of energy metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00143	0.0286	CbGpPWpGaD
Levosimendan—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00143	0.00899	CcSEcCtD
Levosimendan—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.00138	0.00871	CcSEcCtD
Levosimendan—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.00138	0.00871	CcSEcCtD
Levosimendan—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00138	0.00869	CcSEcCtD
Levosimendan—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00137	0.00859	CcSEcCtD
Levosimendan—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00136	0.00855	CcSEcCtD
Levosimendan—PDE3A—Nitric oxide stimulates guanylate cyclase—NOS2—chronic obstructive pulmonary disease	0.00136	0.0271	CbGpPWpGaD
Levosimendan—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.00136	0.00853	CcSEcCtD
Levosimendan—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00133	0.00835	CcSEcCtD
Levosimendan—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00131	0.00823	CcSEcCtD
Levosimendan—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.00131	0.00822	CcSEcCtD
Levosimendan—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.00131	0.00822	CcSEcCtD
Levosimendan—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.00131	0.00822	CcSEcCtD
Levosimendan—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.0013	0.00818	CcSEcCtD
Levosimendan—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.0013	0.00817	CcSEcCtD
Levosimendan—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.0013	0.00817	CcSEcCtD
Levosimendan—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00129	0.0081	CcSEcCtD
Levosimendan—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00128	0.00806	CcSEcCtD
Levosimendan—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.00128	0.00805	CcSEcCtD
Levosimendan—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.00128	0.00804	CcSEcCtD
Levosimendan—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00126	0.00792	CcSEcCtD
Levosimendan—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00124	0.0078	CcSEcCtD
Levosimendan—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.00123	0.00776	CcSEcCtD
Levosimendan—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.00123	0.00771	CcSEcCtD
Levosimendan—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00119	0.00747	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.00118	0.0236	CbGpPWpGaD
Levosimendan—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00113	0.00713	CcSEcCtD
Levosimendan—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00112	0.00706	CcSEcCtD
Levosimendan—KCNJ8—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00111	0.0221	CbGpPWpGaD
Levosimendan—PDE3A—Nitric oxide stimulates guanylate cyclase—NOS3—chronic obstructive pulmonary disease	0.00109	0.0217	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.00107	0.0213	CbGpPWpGaD
Levosimendan—PDE3A—G alpha (s) signalling events—PDE4A—chronic obstructive pulmonary disease	0.00106	0.0212	CbGpPWpGaD
Levosimendan—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00104	0.00654	CcSEcCtD
Levosimendan—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00104	0.00654	CcSEcCtD
Levosimendan—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00103	0.00651	CcSEcCtD
Levosimendan—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00103	0.00651	CcSEcCtD
Levosimendan—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00102	0.0064	CcSEcCtD
Levosimendan—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00099	0.00623	CcSEcCtD
Levosimendan—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00099	0.00623	CcSEcCtD
Levosimendan—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000981	0.00617	CcSEcCtD
Levosimendan—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000977	0.00614	CcSEcCtD
Levosimendan—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000958	0.00603	CcSEcCtD
Levosimendan—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000958	0.00603	CcSEcCtD
Levosimendan—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000953	0.00599	CcSEcCtD
Levosimendan—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000939	0.00591	CcSEcCtD
Levosimendan—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000935	0.00588	CcSEcCtD
Levosimendan—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000921	0.00579	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000915	0.00576	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000915	0.00576	CcSEcCtD
Levosimendan—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000906	0.0057	CcSEcCtD
Levosimendan—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000906	0.0057	CcSEcCtD
Levosimendan—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000905	0.00569	CcSEcCtD
Levosimendan—KCNJ8—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000904	0.018	CbGpPWpGaD
Levosimendan—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000896	0.00564	CcSEcCtD
Levosimendan—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000885	0.00557	CcSEcCtD
Levosimendan—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000872	0.00549	CcSEcCtD
Levosimendan—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000869	0.00547	CcSEcCtD
Levosimendan—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000868	0.00546	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000864	0.00543	CcSEcCtD
Levosimendan—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000856	0.00538	CcSEcCtD
Levosimendan—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000835	0.00525	CcSEcCtD
Levosimendan—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000827	0.0052	CcSEcCtD
Levosimendan—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000823	0.00517	CcSEcCtD
Levosimendan—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00078	0.00491	CcSEcCtD
Levosimendan—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000772	0.00486	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000741	0.0148	CbGpPWpGaD
Levosimendan—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000725	0.00456	CcSEcCtD
Levosimendan—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000725	0.00456	CcSEcCtD
Levosimendan—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00071	0.00447	CcSEcCtD
Levosimendan—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000701	0.00441	CcSEcCtD
Levosimendan—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000701	0.00441	CcSEcCtD
Levosimendan—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000686	0.00432	CcSEcCtD
Levosimendan—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000685	0.00431	CcSEcCtD
Levosimendan—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000674	0.00424	CcSEcCtD
Levosimendan—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000674	0.00424	CcSEcCtD
Levosimendan—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000664	0.00418	CcSEcCtD
Levosimendan—Headache—Formoterol—chronic obstructive pulmonary disease	0.000664	0.00418	CcSEcCtD
Levosimendan—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000662	0.00416	CcSEcCtD
Levosimendan—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00066	0.00415	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000656	0.0131	CbGpPWpGaD
Levosimendan—Headache—Montelukast—chronic obstructive pulmonary disease	0.00065	0.00409	CcSEcCtD
Levosimendan—KCNJ11—Type II diabetes mellitus—TNF—chronic obstructive pulmonary disease	0.00064	0.0128	CbGpPWpGaD
Levosimendan—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000636	0.004	CcSEcCtD
Levosimendan—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000629	0.00396	CcSEcCtD
Levosimendan—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000629	0.00396	CcSEcCtD
Levosimendan—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000627	0.00394	CcSEcCtD
Levosimendan—KCNJ11—FOXA2 and FOXA3 transcription factor networks—ALB—chronic obstructive pulmonary disease	0.000622	0.0124	CbGpPWpGaD
Levosimendan—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000617	0.00388	CcSEcCtD
Levosimendan—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000594	0.00374	CcSEcCtD
Levosimendan—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.00056	0.00352	CcSEcCtD
Levosimendan—PDE3A—G alpha (s) signalling events—ADRB2—chronic obstructive pulmonary disease	0.000538	0.0107	CbGpPWpGaD
Levosimendan—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000533	0.00335	CcSEcCtD
Levosimendan—PDE3A—Platelet homeostasis—NOS2—chronic obstructive pulmonary disease	0.000528	0.0105	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000525	0.0105	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.000522	0.0104	CbGpPWpGaD
Levosimendan—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000519	0.00327	CcSEcCtD
Levosimendan—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000514	0.00324	CcSEcCtD
Levosimendan—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000511	0.00321	CcSEcCtD
Levosimendan—PDE3A—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.000456	0.0091	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000428	0.00853	CbGpPWpGaD
Levosimendan—PDE3A—Platelet homeostasis—NOS3—chronic obstructive pulmonary disease	0.000425	0.00847	CbGpPWpGaD
Levosimendan—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000409	0.00257	CcSEcCtD
Levosimendan—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000407	0.00256	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000405	0.00808	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000389	0.00775	CbGpPWpGaD
Levosimendan—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00038	0.00239	CcSEcCtD
Levosimendan—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000377	0.00237	CcSEcCtD
Levosimendan—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00036	0.00226	CcSEcCtD
Levosimendan—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000357	0.00224	CcSEcCtD
Levosimendan—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000341	0.00214	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000329	0.00656	CbGpPWpGaD
Levosimendan—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000285	0.00179	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.000282	0.00563	CbGpPWpGaD
Levosimendan—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000276	0.00173	CcSEcCtD
Levosimendan—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000265	0.00167	CcSEcCtD
Levosimendan—PDE3A—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.000262	0.00522	CbGpPWpGaD
Levosimendan—Headache—Prednisone—chronic obstructive pulmonary disease	0.000261	0.00164	CcSEcCtD
Levosimendan—PDE3A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000255	0.00509	CbGpPWpGaD
Levosimendan—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000248	0.00156	CcSEcCtD
Levosimendan—KCNJ11—Metabolism—APIP—chronic obstructive pulmonary disease	0.000248	0.00494	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.000228	0.00454	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000227	0.00453	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000218	0.00436	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000204	0.00406	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000198	0.00396	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000184	0.00366	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000176	0.00351	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000164	0.00327	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.00016	0.00319	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GC—chronic obstructive pulmonary disease	0.00016	0.00318	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000155	0.00308	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000148	0.00296	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000131	0.00262	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000129	0.00257	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000118	0.00236	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000117	0.00234	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.00011	0.0022	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.0001	0.002	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	9.97e-05	0.00199	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—ALB—chronic obstructive pulmonary disease	9.95e-05	0.00198	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	9.87e-05	0.00197	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—NOS3—chronic obstructive pulmonary disease	9.52e-05	0.0019	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	9.44e-05	0.00188	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	8.96e-05	0.00179	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.71e-05	0.00174	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	8.63e-05	0.00172	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GCLC—chronic obstructive pulmonary disease	8.61e-05	0.00172	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CTGF—chronic obstructive pulmonary disease	7.86e-05	0.00157	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	7.84e-05	0.00156	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.24e-05	0.00144	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	6.91e-05	0.00138	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	6.86e-05	0.00137	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—KL—chronic obstructive pulmonary disease	6.42e-05	0.00128	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	6.29e-05	0.00125	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.04e-05	0.0012	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.96e-05	0.00119	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5.92e-05	0.00118	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.55e-05	0.00111	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	5.33e-05	0.00106	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.29e-05	0.00106	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.26e-05	0.00105	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—TP53—chronic obstructive pulmonary disease	5.18e-05	0.00103	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.84e-05	0.000966	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.81e-05	0.00096	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.63e-05	0.000924	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.31e-05	0.000859	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ALB—chronic obstructive pulmonary disease	3.58e-05	0.000713	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.54e-05	0.000706	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NOS3—chronic obstructive pulmonary disease	3.42e-05	0.000682	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.38e-05	0.000674	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.23e-05	0.000643	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.86e-05	0.000571	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.72e-05	0.000543	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.59e-05	0.000516	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.32e-05	0.000464	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.13e-05	0.000425	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.09e-05	0.000417	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.76e-05	0.00035	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.61e-05	0.000321	CbGpPWpGaD
